Ledger.Open graph →
SEC Form D · filed December 15, 2014

FENNEC PHARMACEUTICALS INC

Offering
$2.2M
Sold
$2.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
RESEARCH TRIANGLE PARK, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Chris Rallis · Research Triangle Park, NCDirectorAdrian Haigh · Research Triangle Park, NCDirectorKhalid Islam · Research Triangle Park, NCDirectorRostislav Raykov · Research Triangle Park, NCExec · DirectorSteven Skolsky · RESEARCH TRIANGLE PARK, NCDirectorKrysia Lynes · RESEARCH TRIANGLE PARK, NCExecAdrian Haigh · Research Triangle Park, NCDirectorKhalid Islam · Research Triangle Park, NCDirectorRostislav Raykov · Research Triangle Park, NCExec · DirectorSteven Skolsky · Research Triangle Park, NCDirectorKrysia Lynes · Research Triangle Park, NCExecChris Rallis · Mission Viejo, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗